Earnhart CG - Search Results

1

Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.

Izac JR, Oliver LD Jr, Earnhart CG, Marconi RT. Izac JR, et al. Among authors: earnhart cg. Vaccine. 2017 May 31;35(24):3178-3185. doi: 10.1016/j.vaccine.2017.04.079. Epub 2017 May 4. Vaccine. 2017. PMID: 28479174 Free PMC article.

2

Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.

Rhodes DV, Earnhart CG, Mather TN, Meeus PF, Marconi RT. Rhodes DV, et al. Among authors: earnhart cg. Vet J. 2013 Nov;198(2):412-8. doi: 10.1016/j.tvjl.2013.07.019. Epub 2013 Aug 17. Vet J. 2013. PMID: 23962611 Free PMC article.

3

Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

Earnhart CG, Buckles EL, Dumler JS, Marconi RT. Earnhart CG, et al. Infect Immun. 2005 Dec;73(12):7869-77. doi: 10.1128/IAI.73.12.7869-7877.2005. Infect Immun. 2005. PMID: 16299277 Free PMC article.

4

Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.

Earnhart CG, Buckles EL, Marconi RT. Earnhart CG, et al. Vaccine. 2007 Jan 5;25(3):466-80. doi: 10.1016/j.vaccine.2006.07.052. Epub 2006 Aug 8. Vaccine. 2007. PMID: 16996663

5

Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Buckles EL, Earnhart CG, Marconi RT. Buckles EL, et al. Among authors: earnhart cg. Clin Vaccine Immunol. 2006 Oct;13(10):1162-5. doi: 10.1128/CVI.00099-06. Clin Vaccine Immunol. 2006. PMID: 17028218 Free PMC article.

6

Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Earnhart CG, Marconi RT. Earnhart CG, et al. Vaccine. 2007 Apr 30;25(17):3419-27. doi: 10.1016/j.vaccine.2006.12.051. Epub 2007 Jan 17. Vaccine. 2007. PMID: 17239505 Free PMC article.

7

OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.

Earnhart CG, Marconi RT. Earnhart CG, et al. Clin Vaccine Immunol. 2007 May;14(5):628-34. doi: 10.1128/CVI.00409-06. Epub 2007 Mar 14. Clin Vaccine Immunol. 2007. PMID: 17360854 Free PMC article. Clinical Trial.

8

An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.

Earnhart CG, Marconi RT. Earnhart CG, et al. Hum Vaccin. 2007 Nov-Dec;3(6):281-9. doi: 10.4161/hv.4661. Epub 2007 Jul 2. Hum Vaccin. 2007. PMID: 17921702

9

Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.

Earnhart CG, Rhodes DV, Marconi RT. Earnhart CG, et al. Clin Vaccine Immunol. 2011 Jun;18(6):901-6. doi: 10.1128/CVI.05004-11. Epub 2011 Apr 27. Clin Vaccine Immunol. 2011. PMID: 21525304 Free PMC article.

10

Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.

Oliver LD Jr, Earnhart CG, Virginia-Rhodes D, Theisen M, Marconi RT. Oliver LD Jr, et al. Among authors: earnhart cg. Vet J. 2016 Dec;218:27-33. doi: 10.1016/j.tvjl.2016.11.001. Epub 2016 Nov 9. Vet J. 2016. PMID: 27938705 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters